From: EEG alpha reactivity and cholinergic system integrity in Lewy body dementia and Alzheimer’s disease
HC (N = 40) | AD (N = 21) | LBD (N = 41) | Group differences | |
---|---|---|---|---|
Male to female | 25:15 | 14:7 | 35:6 | χ2 = 5.8, p = 0.06a |
Age | 73.4 (6.6) | 74.7 (7.2) | 74.6 (6.5) | F(2, 99) = 0.4, p = 0.66b |
AChEI | – | 20 | 35 | χ2 = 1.4, p = 0.25c |
PD meds | – | 0 | 28 | χ2 = 26.2, p < 0.001c |
Duration | – | 4.1 (2.4)f | 3.2 (2.1)g | U = 270, p = 0.07d |
MMSE | 28.8 (1.1) | 21.6 (3.7) | 23.1 (3.8) | t60 = 1.5, p = 0.15e |
UPDRS III | 3.9 (4.2) | 1.7 (1.5) | 20.2 (8.6) | t60 = 9.7, p < 0.001e |
CAF total | – | 0.3 (0.7)h | 5.2 (4.3)j | t56 = 5.1, p < 0.001e |
Mayo total | – | 9.4 (4.4)h | 14.3 (5.5)j | t56 = 3.5, p = 0.001e |
Mayo cogn | – | 2.0 (1.9)h | 3.0 (1.8)j | t56 = 2.0, p = 0.05e |
NPI total | – | 7.4 (7.2)h | 14.5 (10.5)g | t58 = 2.7, p = 0.009e |
NPI hall | – | 0.05 (0.2)h | 2.0 (2.0)g | t58 = 4.5, p < 0.001e |